Many COVID-19 Cost-Sharing Waivers Are Set to Expire

Although federal relief legislation tied to the pandemic required health insurers to waive cost sharing for COVID-19 testing, not treatment, many plans opted to do both anyway. In fact, a recent analysis from the Kaiser Family Foundation (KFF) found that 80% of enrollees in the individual and fully insured group insurance markets were in plans that voluntarily waived out-of-pocket costs for COVID-19 at some point during the pandemic.

Yet with the public health crisis ongoing and the race to develop and distribute an effective vaccine far from over, a considerable portion of the commercially insured population may be exposed to hefty hospital bills due to health plans’ cost-sharing waivers expiring. According to the Peterson-KFF Health System Tracker analysis, published Aug. 20, 20% of individual and fully insured group plan enrollees are in plans where a cost-sharing waiver for COVID-19 treatment has already expired, and another 16% are in plans where the waiver is scheduled to expire by the end of September.

0 Comments
© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

doctor-looking-at-screen
March 22

New Billing Codes Led to Explosion of Patient-Messaging Claims

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
March 22

News Briefs: ACA Plan Signups Totaled 21M During 2024 Open Enrollment

READ MORE
magnifying-glass
March 22

GAO Urges CMS to Collect Better Data on Appeals, Grievances in Managed Medicaid

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today